Target intelligence / Profile preview

Mitochondrial import receptor subunit TOM22 homolog (TOMM22)

Target
TOMM22
Molecular classification
Transporter (outer mitochondrial membrane translocase complex subunit), Receptor (functions in protein recognition and import), Other (integral membrane protein, part of multisubunit complex)
01

Overview

Mitochondrial import receptor subunit TOM22 homolog (TOMM22) is an integral outer mitochondrial membrane protein and a core component of the translocase of the outer mitochondrial membrane (TOM) complex, which serves as the primary gateway for protein import into mitochondria. TOMM22 functions as a receptor for preproteins carrying N-terminal mitochondrial targeting signals, working together with TOM20, TOM70, and the central pore-forming subunit TOM40. TOMM22 possesses a single transmembrane α-helical segment, with soluble domains exposed to the cytosol and the intermembrane space; its cytosolic domain has a three-helix bundle structure essential for preprotein recognition and translocation. TOMM22 also stabilizes the TOM complex and is required for its assembly and function. Altered TOMM22 activity or expression is linked to neurodegenerative and cardiac disease, and it is overexpressed in some cancers, making it of emerging interest for disease research and potential biomarker development.

Other names
TOMM22TOM22hTom22Translocase of outer membrane 22 kDa subunit homolog1C9-2MST065MSTP065mitochondrial import receptor subunit TOM22 homologmitochondrial import receptor Tom22
02

Mechanism of action

Not applicable (no drugs or drug classes with characterized mechanisms targeting TOMM22 directly). Mechanisms of action are currently research-based, focusing on protein import disruption or modulation in cellular/animal models.

03

Biological functions

Protein import into mitochondria (recognizes and translocates preproteins across the outer membrane)Complex stabilization (stabilizes the TOM complex)Signal recognition (binds and guides N-terminal mitochondrial targeting signals on precursor proteins)
04

Disease associations

Neurodegenerative disease (deficiency has been linked with neurodegeneration)Cardiac pathology (implicated in heart diseases)Cancer (potential roles in metabolic adaptation and observed overexpression in certain cancers)
05

Safety considerations

Mitochondrial toxicity (theoretical, as disrupting TOMM22 may broadly impair mitochondrial function and cell viability)Off-target effects (any therapeutic targeting would risk interfering with essential cellular bioenergetics)
06

Interacting drugs

None established (TOMM22 is not currently listed as a direct drug target and no approved drugs are known to specifically modulate TOMM22 function. It is, however, being investigated in mitochondrial research and as a potential diagnostic/therapeutic target.)
07

Biomarkers

Elevated TOMM22 expression (may be used as a biomarker in research studies involving mitochondrial function or disease states such as cancer)

Beyond the preview

Go deeper on Mitochondrial import receptor subunit TOM22 homolog (TOMM22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial import receptor subunit TOM22 homolog (TOMM22).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call